Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_4
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 42 (66.7%)

Trials by Status

unknown133%
terminated133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_4

Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery

NCT04244981
unknownphase_2

Prehospital Kcentra for Hemorrhagic Shock

NCT04019015
completedphase_4

PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding

NCT02557672

Clinical Trials (3)

Showing 3 of 3 trials
NCT04244981Phase 4

Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery

Terminated
NCT04019015Phase 2

Prehospital Kcentra for Hemorrhagic Shock

Unknown
NCT02557672Phase 4

PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3